CV Sciences is a small U.S. consumer health and wellness company that sells hemp-derived CBD products and plant-based food products. The core business is hemp-derived CBD, sold under the +PlusCBD brand through roughly 2,500 brick-and-mortar retail stores and direct-to-consumer websites. The +PlusCBD lineup includes softgels, tinctures, topicals, gummies, and pet products. CV Sciences claims +PlusCBD is the top-selling hemp extract brand in the U.S. natural products retail channel. In 2024, CV Sciences launched +PlusHLTH, a cannabinoid-free supplement line, to reduce dependence on CBD-specific regulatory outcomes. The secondary business is plant-based food — shelf-stable, vegan, gluten-free alternatives to meat, eggs, and cheese — sold in Europe through the Cultured Foods subsidiary and, as of early 2025, in the U.S. under the Lunar Fox brand. CV Sciences also operates a contract manufacturing business (acquired in 2024) that produces softgels and tinctures for third-party supplement companies. Revenue is split roughly 55-60% retail and 40-45% direct-to-consumer. CV Sciences has historically relied on third-party manufacturers, but is actively in-sourcing production to improve gross margins. The company is also pursuing acquisitions to add revenue and expand distribution. A key risk is regulatory: a November 2025 law redefines hemp using a total THC standard that would restrict most CBD products currently on the market, effective November 2026, unless Congress intervenes.